Found 513 results
Cytokinetics is set to submit aficamten for FDA approval, potentially the first drug approved for non-obstructive hypert...
AstraZeneca's heart disease trial disappoints, showing no added benefit, while a court affirms FDA's handling of drug sh...
Members of a federal autism advisory committee controversially endorse vaccines as a cause of autism, despite overwhelmi...
AstraZeneca and Ionis' heart disease treatment faced an unexpected failure, raising concerns and interest among biotech...
The Lindsay Clancy case highlights systemic flaws in maternal mental health care, raising concerns about its impact on p...
Novartis' latest drug, pacibekitug, successfully reduces inflammation in a Phase 2 study, suggesting potential for cardi...
Recent analyses indicate that post-Dobbs predictions about abortion rates and health impacts may not align with current...
Addressing women's health disparities could generate significant economic gains, with estimates suggesting a $1 trillion...
A new wave of drug trials aims to tackle genetic heart disease risk factors, particularly targeting Lp(a), with major im...
A notable drop in GLP-1 drug coverage among U.S. employers coincides with a decline in Massachusetts' biotech workforce,...
Recent findings highlight the surprising surge in health care costs for major companies, prompting scrutiny and reevalua...
The newsletter recalls Vox’s music explainers and points readers to a video tracing the origins of the “Gen Alpha Melody...
Pharmaceutical giants are poised to unveil data on new cardiovascular drugs targeting lipoprotein(a), marking a potentia...
The FDA has approved Rasonque, a novel treatment for advanced pancreatic cancer, showing significant improvements in pat...
Recent studies highlight how coronary artery calcium scans can inform statin treatment decisions, especially in borderli...
Health Secretary Robert F. Kennedy Jr. faces backlash over vaccine misinformation as PA confirms measles-related deaths;...
Healthcare providers are increasingly adopting AI chatbots to navigate complex patient records, improving diagnosis and...
The recent success of Merck and Moderna's personalized mRNA cancer therapy marks a pivotal moment in cancer treatment ad...
Regeneron and Ultragenyx receive FDA approvals for significant therapies aimed at rare diseases, offering new hope for a...
Long-term HIV survivors worry that a cure might jeopardize their essential support services, highlighting the need for t...